Clearmind Medicine Aktie - CMND

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

1,60

Gebot

1,58

Fragen

8,50

Volumen

0,00 Tagesbereich 0,00

1,60 52-Wochen-Bereich 2,02

Handelsende

1,60

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor...

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial Tel Aviv...

Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic-Derived Obesity Treatment in Pre-Clinical Trial

Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic- Derived Obesity Treatment in Pre-Clinical Trial...

Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute

Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute U.S. Patent and Trademark Office extends...

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial VANCOUVER, Canada...

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	1.6	1.6	1.6	0	0	CS
4	0	0	1.6	1.6	1.6	0	0	CS
12	0	0	1.6	1.6	1.6	0	0	CS
26	0	0	1.6	1.6	1.6	0	0	CS
52	-0.35	-17.9487179487	1.95	2.02	1.6	73	1.86209014	CS
156	-12.95	-89.0034364261	14.55	330	1.25	8647	24.19557136	CS
260	-13.4	-89.3333333333	15	330	1.25	11418	23.87897912	CS

CMND - Frequently Asked Questions (FAQ)

What is the current Clearmind Medicine share price?

The current share price of Clearmind Medicine is $ 1,60

What is the 1 year trading range for Clearmind Medicine share price?

Clearmind Medicine has traded in the range of $ 1,60 to $ 2,02 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
JSDAJones Soda Co	$ 0,335 (1.240,00%)	20,41k
XIGMXigem Technologies Corporation	$ 0,01 (100,00%)	52k
AFXArctic Fox Lithium Corp	$ 0,01 (100,00%)	51,82k
POWRPOWR Lithium Corp	$ 0,05 (66,67%)	44,76k
HPSSHybrid Power Solutions Inc	$ 0,065 (62,50%)	4,73M
GCA.XGencan Capital Inc	$ 0,01 (-75,00%)	2,28k
ETIEnviroMetal Technologies Inc	$ 0,005 (-66,67%)	1,14k
CGIICleanGo Innovations Inc	$ 0,125 (-54,55%)	38,3k
FNQFineqia International Inc	$ 0,005 (-50,00%)	27k
LTHMChampion Electric Metals Inc	$ 0,005 (-50,00%)	67,03k
HPSSHybrid Power Solutions Inc	$ 0,065 (62,50%)	4,73M
QIMCQuebec Innovative Materials Corp	$ 0,13 (4,00%)	2,53M
PUMPStock Trend Capital Inc	$ 0,01 (0,00%)	2,31M
WHIPCredissential Inc	$ 0,035 (-12,50%)	1,69M
CSSCascada Silver Corp	$ 0,035 (16,67%)	1,65M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Clearmind Medicine Inc (CMND)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

CMND Neueste Nachrichten

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial

Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic-Derived Obesity Treatment in Pre-Clinical Trial

Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment

CMND - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Clearmind Medicine Inc (CMND) Börsenkurse

Clearmind Medicine Inc (CMND)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

CMND Neueste Nachrichten

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial

Israel-Based Clearmind Medicine Shows Efficacy of Psychedelic-Derived Obesity Treatment in Pre-Clinical Trial

Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment

CMND - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen